Other Non-Current Liabilities
Johnson & Johnson Other Non-Current Liabilities increased by 3.4% to $10.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $10.44B to $10.21B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -3.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.72B | $11.18B | $10.69B | $10.50B | $10.52B | $9.92B | $10.15B | $14.42B | $14.58B | $13.56B | $13.40B | $15.07B | $14.09B | $14.92B | $17.55B | $10.44B | $10.26B | $9.93B | $9.87B | $10.21B |
| QoQ Change | — | -12.2% | -4.4% | -1.8% | +0.3% | -5.8% | +2.3% | +42.1% | +1.1% | -7.0% | -1.2% | +12.5% | -6.5% | +5.9% | +17.6% | -40.5% | -1.6% | -3.3% | -0.6% | +3.4% |
| YoY Change | — | — | — | — | -17.3% | -11.3% | -5.1% | +37.4% | +38.6% | +36.7% | +32.1% | +4.5% | -3.4% | +10.0% | +31.0% | -30.7% | -27.1% | -33.5% | -43.8% | -2.2% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other non-current liabilities?
- Johnson & Johnson (JNJ) reported other non-current liabilities of $10.21B in Q1 2026.
- How has Johnson & Johnson's other non-current liabilities changed year-over-year?
- Johnson & Johnson's other non-current liabilities decreased by 2.2% year-over-year, from $10.44B to $10.21B.
- What is the long-term trend for Johnson & Johnson's other non-current liabilities?
- Over 5 years (2020 to 2025), Johnson & Johnson's other non-current liabilities has grown at a -3.7% compound annual growth rate (CAGR), from $11.94B to $9.87B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.